Dissertation to obtain the Master of Science Degree in Biomedical Engineering: Specialization in Biomolecular, Tissue and Organ Engineering
暂无分享,去创建一个
[1] J. Seelig,et al. Contributions of glycosaminoglycan binding and clustering to the biological uptake of the nonamphipathic cell-penetrating peptide WR9. , 2011, Biochemistry.
[2] R. Dutch,et al. Viral entry mechanisms: the increasing diversity of paramyxovirus entry , 2009, The FEBS journal.
[3] J. Langedijk. Translocation Activity of C-terminal Domain of Pestivirus Erns and Ribotoxin L3 Loop* , 2002, The Journal of Biological Chemistry.
[4] Vladimir B. Bajic,et al. DAMPD: a manually curated antimicrobial peptide database , 2011, Nucleic Acids Res..
[5] David R. Liu,et al. Mammalian cell penetration, siRNA transfection, and DNA transfection by supercharged proteins , 2009, Proceedings of the National Academy of Sciences.
[6] S. Henriques,et al. Re‐evaluating the role of strongly charged sequences in amphipathic cell‐penetrating peptides , 2005, FEBS letters.
[7] N. C. Price,et al. How to study proteins by circular dichroism. , 2005, Biochimica et biophysica acta.
[8] M. Ferrer,et al. Effects of cargo molecules on the cellular uptake of arginine-rich cell-penetrating peptides. , 2005, Biochimica et biophysica acta.
[9] S. Futaki,et al. Arginine-rich Peptides , 2001, The Journal of Biological Chemistry.
[10] Annick Thomas,et al. Structural polymorphism of two CPP: an important parameter of activity. , 2008, Biochimica et biophysica acta.
[11] M. Rossmann,et al. A structural perspective of the flavivirus life cycle , 2005, Nature Reviews Microbiology.
[12] Kumardeep Chaudhary,et al. Cell Penetrating Peptides , 2016 .
[13] A. Arranja,et al. Preclinical development of siRNA therapeutics: towards the match between fundamental science and engineered systems. , 2014, Nanomedicine : nanotechnology, biology, and medicine.
[14] Miguel A R B Castanho,et al. Cell-penetrating peptides and antimicrobial peptides: how different are they? , 2006, The Biochemical journal.
[15] Caroline Louis-Jeune,et al. Prediction of protein secondary structure from circular dichroism using theoretically derived spectra , 2012, Proteins.
[16] Kevin W Eliceiri,et al. NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.
[17] B. Nordén,et al. Membrane binding and translocation of cell-penetrating peptides. , 2004, Biochemistry.
[18] Charles L. Brooks,et al. Viral Capsid Proteins Are Segregated in Structural Fold Space , 2013, PLoS Comput. Biol..
[19] U. Theuretzbacher. Global antibacterial resistance: The never-ending story. , 2013, Journal of global antimicrobial resistance.
[20] M. Castanho,et al. The Mechanism of Action of Antimicrobial Peptides: Lipid Vesicles vs. Bacteria , 2012, Front. Immun..
[21] Blood pressure modulation following activation of mast cells by cationic cell penetrating peptides , 2011, Peptides.
[22] N. C. Santos,et al. Lipossomas: a bala mágica acertou? , 2002 .
[23] K. Chou,et al. iAMP-2L: a two-level multi-label classifier for identifying antimicrobial peptides and their functional types. , 2013, Analytical biochemistry.
[24] M. Morris,et al. Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics , 2009, British journal of pharmacology.
[25] Astrid Gräslund,et al. Mechanisms of Cellular Uptake of Cell-Penetrating Peptides , 2011, Journal of biophysics.
[26] S. Futaki,et al. Cell-surface accumulation of flock house virus-derived peptide leads to efficient internalization via macropinocytosis. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.
[27] D. Craik,et al. Design and characterization of novel antimicrobial peptides, R-BP100 and RW-BP100, with activity against Gram-negative and Gram-positive bacteria. , 2013, Biochimica et biophysica acta.
[28] Daniel W. A. Buchan,et al. Scalable web services for the PSIPRED Protein Analysis Workbench , 2013, Nucleic Acids Res..
[29] R. Mrsny,et al. Cell penetrating peptides fail to induce an innate immune response in epithelial cells in vitro: implications for continued therapeutic use. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[30] D. Andreu,et al. Peptides as models for the structure and function of viral capsid proteins: Insights on dengue virus capsid. , 2013, Biopolymers.
[31] Tina N. Davis,et al. A class of human proteins that deliver functional proteins into mammalian cells in vitro and in vivo. , 2011, Chemistry & biology.
[32] D. Andreu,et al. Quantifying molecular partition of cell‐penetrating peptide–cargo supramolecular complexes into lipid membranes: optimizing peptide‐based drug delivery systems , 2013, Journal of peptide science : an official publication of the European Peptide Society.
[33] T. Hökfelt,et al. Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo , 1998, Nature Biotechnology.
[34] P. Boisguérin,et al. Comparison of cellular uptake using 22 CPPs in 4 different cell lines. , 2008, Bioconjugate chemistry.
[35] G. Divita. Bioactive cell-penetrating peptides: kill two birds with one stone. , 2010, Chemistry & biology.
[36] D. Andreu,et al. Nucleic acid delivery by cell penetrating peptides derived from dengue virus capsid protein: design and mechanism of action , 2014, The FEBS journal.
[37] James S Murday,et al. Translational nanomedicine: status assessment and opportunities. , 2009, Nanomedicine : nanotechnology, biology, and medicine.
[38] S. Piotto,et al. YADAMP: yet another database of antimicrobial peptides. , 2012, International journal of antimicrobial agents.
[39] Mark Marsh,et al. Virus Entry: Open Sesame , 2006, Cell.
[40] G. Wong,et al. Arginine‐rich cell‐penetrating peptides , 2010, FEBS letters.
[41] S. Schwarze,et al. In vivo protein transduction: delivery of a biologically active protein into the mouse. , 1999, Science.
[42] Shana O Kelley,et al. Recent advances in the use of cell-penetrating peptides for medical and biological applications. , 2009, Advanced drug delivery reviews.
[43] J. Leroux,et al. Is there a future for cell-penetrating peptides in oligonucleotide delivery? , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[44] H Fessi,et al. Gene therapy and DNA delivery systems. , 2014, International journal of pharmaceutics.
[45] R. Brock,et al. Cell surface clustering of heparan sulfate proteoglycans by amphipathic cell-penetrating peptides does not contribute to uptake. , 2013, Journal of controlled release : official journal of the Controlled Release Society.
[46] David R. Liu,et al. Engineering and identifying supercharged proteins for macromolecule delivery into mammalian cells. , 2012, Methods in enzymology.
[47] Seong-Cheol Park,et al. The Role of Antimicrobial Peptides in Preventing Multidrug-Resistant Bacterial Infections and Biofilm Formation , 2011, International journal of molecular sciences.
[48] Ű. Langel,et al. Predicting cell-penetrating peptides. , 2008, Advanced drug delivery reviews.
[49] Ű. Langel,et al. Cargo-dependent cytotoxicity and delivery efficacy of cell-penetrating peptides: a comparative study. , 2007, The Biochemical journal.
[50] P. Netti,et al. A peptide derived from herpes simplex virus type 1 glycoprotein H: membrane translocation and applications to the delivery of quantum dots. , 2011, Nanomedicine : nanotechnology, biology, and medicine.
[51] Andrei N. Lupas,et al. CLANS: a Java application for visualizing protein families based on pairwise similarity , 2004, Bioinform..
[52] M. X. Fernandes,et al. Escherichia coli Cell Surface Perturbation and Disruption Induced by Antimicrobial Peptides BP100 and pepR* , 2010, The Journal of Biological Chemistry.
[53] Nuno G. Azoia,et al. The activity of LE10 peptide on biological membranes using molecular dynamics, in vitro and in vivo studies. , 2013, Colloids and surfaces. B, Biointerfaces.
[54] D. Fatouros,et al. Personalized nanomedicine: paving the way to the practical clinical utility of genomics and nanotechnology advancements. , 2012, Advanced drug delivery reviews.
[55] R. Brasseur,et al. New basic membrane-destabilizing peptides for plasmid-based gene delivery in vitro and in vivo. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.
[56] C. Kao,et al. Cell-penetrating peptides derived from viral capsid proteins. , 2011, Molecular plant-microbe interactions : MPMI.
[57] I. Alves,et al. Membrane Crossover by Cell-Penetrating Peptides: Kinetics and Mechanisms – From Model to Cell Membrane Perturbation by Permeant Peptides , 2011 .
[58] David R. Liu,et al. Potent Delivery of Functional Proteins into Mammalian Cells in Vitro and in Vivo Using a Supercharged Protein , 2010, ACS chemical biology.
[59] Priscille Brodin,et al. A Truncated HIV-1 Tat Protein Basic Domain Rapidly Translocates through the Plasma Membrane and Accumulates in the Cell Nucleus* , 1997, The Journal of Biological Chemistry.
[60] M. Morris,et al. A non-covalent peptide-based strategy for siRNA delivery. , 2007, Biochemical Society transactions.
[61] M. Aguilar,et al. Fast membrane association is a crucial factor in the peptide pep‐1 translocation mechanism: A kinetic study followed by surface plasmon resonance , 2010, Biopolymers.
[62] M. Morris,et al. Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy. , 2008, Advanced drug delivery reviews.
[63] Michele Magrane,et al. UniProt Knowledgebase: a hub of integrated protein data , 2011, Database J. Biol. Databases Curation.
[64] Dominique Douguet,et al. HELIQUEST: a web server to screen sequences with specific alpha-helical properties , 2008, Bioinform..
[65] S. Parveen,et al. Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging. , 2012, Nanomedicine : nanotechnology, biology, and medicine.
[66] A. Ulrich,et al. Dynamical structure of the short multifunctional peptide BP100 in membranes. , 2014, Biochimica et biophysica acta.
[67] A. Thomas,et al. Relationships between the orientation and the structural properties of peptides and their membrane interactions. , 2008, Biochimica et biophysica acta.
[68] J. Švitel,et al. Optical Spectroscopic Methods for the Analysis of Biological Macromolecules , 2013 .
[69] I. Alves,et al. Membrane interactions of two arginine-rich peptides with different cell internalization capacities. , 2012, Biochimica et biophysica acta.
[70] Qihao Zhang,et al. Overview on the recent study of antimicrobial peptides: Origins, functions, relative mechanisms and application , 2012, Peptides.
[71] J. Rossi,et al. The Potential and Current Progress of Internalizing Molecules in Targeted Drug Delivery , 2011 .
[72] S. Dowdy,et al. Do cell-penetrating peptides actually "penetrate" cellular membranes? , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.
[73] G. Barratt. Delivery to Intracellular Targets by Nanosized Particles , 2011 .
[74] Ana Salomé Veiga,et al. Anticancer peptide SVS-1: efficacy precedes membrane neutralization. , 2012, Biochemistry.
[75] S. Sagan,et al. Cell‐penetrating peptides: 20 years later, where do we stand? , 2013, FEBS letters.
[76] N. Santos,et al. Unravelling the molecular basis of the selectivity of the HIV-1 fusion inhibitor sifuvirtide towards phosphatidylcholine-rich rigid membranes. , 2010, Biochimica et biophysica acta.
[77] Amos Bairoch,et al. ViralZone: a knowledge resource to understand virus diversity , 2010, Nucleic Acids Res..
[78] Nir Ben-Tal,et al. Monte Carlo simulations of peptide–membrane interactions with the MCPep web server† , 2012, Nucleic Acids Res..
[79] Alexandro Rodríguez-Rojas,et al. Antibiotics and antibiotic resistance: a bitter fight against evolution. , 2013, International journal of medical microbiology : IJMM.
[80] Gianluca Pollastri,et al. CPPpred: prediction of cell penetrating peptides , 2013, Bioinform..
[81] Irene Martín,et al. Design, Synthesis and Characterization of a New Anionic Cell‐Penetrating Peptide: SAP(E) , 2011, Chembiochem : a European journal of chemical biology.
[82] N. Kamei,et al. One-month subchronic toxicity study of cell-penetrating peptides for insulin nasal delivery in rats. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[83] Eric Vives,et al. Cell-penetrating Peptides , 2003, The Journal of Biological Chemistry.
[84] Shreyas Karnik,et al. ClassAMP: A Prediction Tool for Classification of Antimicrobial Peptides , 2012, IEEE/ACM Transactions on Computational Biology and Bioinformatics.
[85] V. Kairys,et al. Interaction of antimicrobial peptides, BP100 and pepR, with model membrane systems as explored by Brownian dynamics simulations on a coarse-grained model. , 2012, Biopolymers.
[86] W. Shen,et al. Conjugation with cationic cell-penetrating peptide increases pulmonary absorption of insulin. , 2009, Molecular pharmaceutics.
[87] I. Neundorf,et al. Antimicrobial peptides with cell-penetrating peptide properties and vice versa , 2011, European Biophysics Journal.
[88] Gert Storm,et al. Endosomal escape pathways for delivery of biologicals. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[89] A. Bunker,et al. Tat(48-60) peptide amino acid sequence is not unique in its cell penetrating properties and cell-surface glycosaminoglycans inhibit its cellular uptake. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[90] David Andreu,et al. AMPA: an automated web server for prediction of protein antimicrobial regions , 2012, Bioinform..
[91] E. Hildt,et al. Novel cell permeable motif derived from the PreS2-domain of hepatitis-B virus surface antigens , 2000, Gene Therapy.
[92] U. Haberkorn,et al. The pharmacokinetics of cell-penetrating peptides. , 2010, Molecular pharmaceutics.
[93] S. Read,et al. Cell penetrating peptide POD mediates delivery of recombinant proteins to retina, cornea and skin , 2010, Vision Research.
[94] Margarida Bastos,et al. Role of lipids in the interaction of antimicrobial peptides with membranes. , 2012, Progress in lipid research.
[95] R. Mohana-Borges,et al. Intracellular Nucleic Acid Delivery by the Supercharged Dengue Virus Capsid Protein , 2013, PloS one.
[96] Gajendra P. S. Raghava,et al. Analysis and prediction of antibacterial peptides , 2007, BMC Bioinformatics.
[97] B. Lebleu,et al. Comparison of basic peptides- and lipid-based strategies for the delivery of splice correcting oligonucleotides. , 2006, Biochimica et biophysica acta.
[98] R. Brasseur,et al. Happy birthday cell penetrating peptides: already 20 years. , 2010, Biochimica et biophysica acta.
[99] K. Peremans,et al. Chemical-Functional Diversity in Cell-Penetrating Peptides , 2013, PloS one.
[100] I. Alves,et al. Different membrane behaviour and cellular uptake of three basic arginine-rich peptides. , 2011, Biochimica et biophysica acta.
[101] Xue-Qing Zhang,et al. Interactions of nanomaterials and biological systems: Implications to personalized nanomedicine. , 2012, Advanced drug delivery reviews.
[102] M. Hong,et al. Conformational disorder of membrane peptides investigated from solid-state NMR line widths and line shapes. , 2011, The journal of physical chemistry. B.
[103] Gajendra P. S. Raghava,et al. AntiBP2: improved version of antibacterial peptide prediction , 2010, BMC Bioinformatics.
[104] N. Greenfield. Applications of circular dichroism in protein and peptide analysis , 1999 .
[105] A. Phelan,et al. Intercellular delivery of functional p53 by the herpesvirus protein VP22 , 1998, Nature Biotechnology.
[106] M. Morris,et al. The peptide carrier Pep-1 forms biologically efficient nanoparticle complexes. , 2007, Biochemical and biophysical research communications.
[107] Richard J Kuhn,et al. Structural proteomics of dengue virus. , 2008, Current opinion in microbiology.
[108] T. Nylander,et al. Model cell membranes: discerning lipid and protein contributions in shaping the cell. , 2014, Advances in colloid and interface science.
[109] Gajendra P.S. Raghava,et al. PEPstr: a de novo method for tertiary structure prediction of small bioactive peptides. , 2007, Protein and peptide letters.
[110] Steven F Dowdy,et al. Exogenous siRNA delivery using peptide transduction domains/cell penetrating peptides. , 2007, Advanced drug delivery reviews.
[111] A. Prochiantz,et al. The third helix of the Antennapedia homeodomain translocates through biological membranes. , 1994, The Journal of biological chemistry.
[112] R. Salvayre,et al. Colloidal systems for drug delivery: from design to therapy. , 2012, Trends in biotechnology.
[113] Ülo Langel,et al. Cell entry and antimicrobial properties of eukaryotic cell‐ penetrating peptides , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[114] H. Harashima,et al. Learning from the Viral Journey: How to Enter Cells and How to Overcome Intracellular Barriers to Reach the Nucleus , 2009, The AAPS Journal.
[115] Mauro Giacca,et al. Virus-mediated gene delivery for human gene therapy. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[116] G. Divita,et al. Interactions of amphipathic CPPs with model membranes. , 2011, Methods in molecular biology.
[117] M. Castanho,et al. From antimicrobial to anticancer peptides. A review , 2013, Front. Microbiol..
[118] R. Patlolla,et al. (31)P solid-state NMR based monitoring of permeation of cell penetrating peptides into skin. , 2014, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[119] I. Mäger,et al. In vivo biodistribution and efficacy of peptide mediated delivery. , 2010, Trends in pharmacological sciences.
[120] M. Morris,et al. A peptide carrier for the delivery of biologically active proteins into mammalian cells , 2001, Nature Biotechnology.
[121] B. Davidson,et al. Transvascular delivery of small interfering RNA to the central nervous system , 2007, Nature.
[122] R. Epand,et al. Membrane-active peptides and the clustering of anionic lipids. , 2012, Biophysical journal.
[123] I. Alves,et al. Cell biology meets biophysics to unveil the different mechanisms of penetratin internalization in cells. , 2010, Biochimica et biophysica acta.
[124] D. Craik,et al. The Future of Peptide‐based Drugs , 2013, Chemical biology & drug design.
[125] Ari Helenius,et al. How Viruses Enter Animal Cells , 2004, Science.
[126] P. Cullis,et al. Drug Delivery Systems: Entering the Mainstream , 2004, Science.
[127] H. Moulton,et al. Morpholinos and their peptide conjugates: therapeutic promise and challenge for Duchenne muscular dystrophy. , 2010, Biochimica et biophysica acta.
[128] James D. Thompson. Clinical development of synthetic siRNA therapeutics , 2013 .
[129] N. Santos,et al. Interaction of peptides with biomembranes assessed by potential‐sensitive fluorescent probes , 2008, Journal of peptide science : an official publication of the European Peptide Society.
[130] Jo Wixon,et al. Gene therapy clinical trials worldwide to 2007—an update , 2007, The journal of gene medicine.
[131] K. Pattabiraman,et al. The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[132] A. Jones,et al. Cell entry of cell penetrating peptides: tales of tails wagging dogs. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[133] Marco M. Domingues,et al. What can light scattering spectroscopy do for membrane‐active peptide studies? , 2008, Journal of peptide science : an official publication of the European Peptide Society.
[134] Xiaowei Zhao,et al. LAMP: A Database Linking Antimicrobial Peptides , 2013, PloS one.
[135] Wei Zhang,et al. Structure of Dengue Virus Implications for Flavivirus Organization, Maturation, and Fusion , 2002, Cell.
[136] R. Clarke. The dipole potential of phospholipid membranes and methods for its detection. , 2001, Advances in colloid and interface science.
[137] P. O'shea,et al. Intermolecular interactions with/within cell membranes and the trinity of membrane potentials: kinetics and imaging. , 2003, Biochemical Society transactions.
[138] Carl O. Pabo,et al. Cellular uptake of the tat protein from human immunodeficiency virus , 1988, Cell.
[139] Ernst Wagner,et al. Therapeutic plasmid DNA versus siRNA delivery: common and different tasks for synthetic carriers. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[140] Shreyas Karnik,et al. CAMP: a useful resource for research on antimicrobial peptides , 2009, Nucleic Acids Res..
[141] P. Fromherz,et al. Orientation of Hemicyanine Dye in Lipid Membrane Measured by Fluorescence Interferometry on a Silicon Chip , 2001 .
[142] Ű. Langel,et al. Secondary structure of cell-penetrating peptides controls membrane interaction and insertion. , 2010, Biochimica et biophysica acta.
[143] H. McLeod,et al. The kinetics and tissue distribution of protein transduction in mice. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[144] K. Hahm,et al. The thin line between cell‐penetrating and antimicrobial peptides: the case of Pep‐1 and Pep‐1‐K , 2011, Journal of peptide science : an official publication of the European Peptide Society.
[145] Xia Li,et al. APD2: the updated antimicrobial peptide database and its application in peptide design , 2008, Nucleic Acids Res..
[146] Shengrong Guo,et al. Recent progress of cell-penetrating peptides as new carriers for intracellular cargo delivery. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[147] Azam Bolhassani,et al. Potential efficacy of cell-penetrating peptides for nucleic acid and drug delivery in cancer. , 2011, Biochimica et biophysica acta.
[148] Octávio L. Franco,et al. Current scenario of peptide-based drugs: the key roles of cationic antitumor and antiviral peptides , 2013, Front. Microbiol..
[149] Gajendra P. S. Raghava,et al. CPPsite: a curated database of cell penetrating peptides , 2012, Database J. Biol. Databases Curation.
[150] R. Meloen,et al. Application, efficiency and cargo-dependence of transport peptides , 2005 .
[151] M. Morris,et al. Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells. , 2003, Nucleic acids research.
[152] Yifan Jiang,et al. Curb challenges of the "Trojan Horse" approach: smart strategies in achieving effective yet safe cell-penetrating peptide-based drug delivery. , 2013, Advanced drug delivery reviews.
[153] Vladimir P Torchilin,et al. Cell-penetrating peptides: breaking through to the other side. , 2012, Trends in molecular medicine.
[154] F. Milletti,et al. Cell-penetrating peptides: classes, origin, and current landscape. , 2012, Drug discovery today.
[155] M. C. Cardoso,et al. Cell-Penetrating Peptides Uptake, Toxicity, and Applications , 2009 .
[156] Huixia Lv,et al. Cell Penetrating Peptides in the Delivery of Biopharmaceuticals , 2012, Biomolecules.
[157] David R. Liu,et al. Cellular uptake mechanisms and endosomal trafficking of supercharged proteins. , 2012, Chemistry & biology.
[158] T. Borsello,et al. Cell Permeable Peptides: A Promising Tool to Deliver Neuroprotective Agents in the Brain , 2010, Pharmaceuticals.
[159] Y. Yoshioka,et al. Comparative study on transduction and toxicity of protein transduction domains , 2008, British journal of pharmacology.
[160] M. Mano,et al. Cell-Penetrating Peptides—Mechanisms of Cellular Uptake and Generation of Delivery Systems , 2010, Pharmaceuticals.
[161] H. M. Nielsen,et al. Antimicrobial and cell-penetrating properties of penetratin analogs: effect of sequence and secondary structure. , 2013, Biochimica et biophysica acta.